P
Padma V. Devarajan
Researcher at Institute of Chemical Technology
Publications - 93
Citations - 2600
Padma V. Devarajan is an academic researcher from Institute of Chemical Technology. The author has contributed to research in topics: Targeted drug delivery & Drug delivery. The author has an hindex of 25, co-authored 89 publications receiving 2093 citations. Previous affiliations of Padma V. Devarajan include University of Mumbai.
Papers
More filters
Journal ArticleDOI
Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.
TL;DR: Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in the Hep G2 cell line suggests extracellular release of DOX as the mechanism of uptake from the nanoparticles.
Journal ArticleDOI
Onion Phases of PEG-8 Distearate
TL;DR: Stable onion phases of the biodegradable surfactant PEG-8 Distearate with high entrapment efficiency and rapid drug release suggests potential application of the onion phases in drug delivery.
Journal ArticleDOI
Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
Maheshkumar P. Soni,Nilakash Shelkar,Rajiv V Gaikwad,Geeta Vanage,Abdul Samad,Padma V. Devarajan +5 more
TL;DR: The high RES uptake suggests BPQ SLN as a promising approach for targeted and improved delivery in theileriosis.
Journal ArticleDOI
Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability
TL;DR: Self nanoprecipitating preconcentrate (SNP) of tamoxifen citrate (TMX), which forms TMX loaded polymeric nanoparticles, on dilution with aqueous media presents a new in situ approach, for design of drug loaded polymer nanoparticles.
Journal ArticleDOI
High-performance thin-layer chromatographic determination of diltiazem hydrochloride as bulk drug and in pharmaceutical preparations
TL;DR: A simple, rapid, selective and precise high-performance thin-layer chromatographic method for the analysis of diltiazem hydrochloride both as a bulk drug and in pharmaceuticals is reported.